|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61P 35/00 |
| (11) | Patento numeris | 2958589 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14706543.7 |
| Europos patento paraiškos padavimo data | 2014-02-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-12-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-11-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/053420 |
| Data | 2014-02-21 |
| (87) | Numeris | WO 2014/128258 |
| Data | 2014-08-28 |
| (30) | Numeris | Data | Šalis |
| 201361768084 P | 2013-02-22 | US | |
| 201361829349 P | 2013-05-31 | US |
| (72) |
WILHELM, Olaf, DE
BEVAN, Paul, GB
FALL, Barbara, DE
KLÖPFER, Pia, DE
|
| (73) |
Heidelberg Pharma AG,
Schriesheimer Strasse 101, 68526 Ladenburg,
DE
|
| (54) | CAIX STRATIFICATION BASED CANCER TREATMENT |
| CAIX STRATIFICATION BASED CANCER TREATMENT |